Company Filing History:
Years Active: 2010
Title: Arundhati Mandal: Innovator in Human Embryonic Stem Cell Research
Introduction
Arundhati Mandal is a notable inventor based in Navi Mumbai, India. He has made significant contributions to the field of stem cell research, particularly in the establishment of human embryonic stem cell lines. His work has implications for regenerative medicine and developmental biology.
Latest Patents
Arundhati Mandal holds a patent for the "Establishment of a human embryonic stem cell line using mammalian cells." This patent describes purified preparations of human embryonic stem cells that exhibit specific population characteristics. The preparation is characterized by the positive expression of pluripotent cell surface markers such as SSEA-4, TRA-1-60, and TRA-1-81, along with a set of ES cell markers including Oct-4, Nanog, and Sox2. The cells are negative for lineage-specific markers and have normal karyotypes, demonstrating high telomerase activity. The embryonic stem cell line, named Relicell™ hES1, retains the ability to differentiate into various cell and tissue types derived from all three embryonic germ layers.
Career Highlights
Arundhati Mandal is associated with Reliance Life Sciences Pvt. Ltd., where he has been instrumental in advancing research in stem cell technology. His innovative work has positioned him as a key figure in the field, contributing to the understanding and application of human embryonic stem cells.
Collaborations
Arundhati has collaborated with notable colleagues such as Shabari Pradeep Tipnis and Geeta Ravindran, who have supported his research endeavors.
Conclusion
Arundhati Mandal's contributions to human embryonic stem cell research highlight his role as an innovator in the field. His patent and ongoing work continue to influence advancements in regenerative medicine.